Beta
ManageSearchChatDiscover
351302

Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients

Article

Last updated: 29 Dec 2024

OverviewSimilar Items

Subjects

-

Tags

-

Abstract

Transcatheter aortic valve implantation (TAVI)
has become an established treatment option for
the treatment of aortic stenosis throughout the
spectrum of surgical risk. Cerebral embolic
protection devices (CEPDs) were developed to 
protect against embolization from the valve or 
vasculature during or post- surgery.

DOI

10.21608/cvrepj.2023.351302

Volume

7

Article Issue

2

Related Issue

47254

Issue Date

2023-12-01

Receive Date

2024-04-22

Publish Date

2023-12-01

Print ISSN

2636-4204

Online ISSN

2636-4212

Article File

CVREPJ3513021701381600.pdf

PDF . 119.6kB

Link

https://cvrepj.journals.ekb.eg/article_351302.html

Detail API

https://cvrepj.journals.ekb.eg/service?article_code=351302

Order

351,302

Type

Abstracts

Type Code

3,139

Publication Type

Journal

Publication Title

Cardiovascular Research Prove Journal

Publication Link

https://cvrepj.journals.ekb.eg/

MainTitle

Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients

Details

Type

Article

Created At

20 Dec 2024